Aortic Stenosis3DP-FASTNCT05484713
Feasibility of 3D Printed Models of Aortic Stenosis in Guiding TAVI Procedure
An observational study of Aortic Stenosis and Valvular Cardiomyopathy, run by Cardio Med Medical Center at 1 site in Romania.
Trial summary
The aim of 3DP-FAST study is to analyze the accuracy of replicating cardiovascular anatomical structures using different techniques and to evaluate the feasibility of 3D printed models of aortic stenosis in guiding TAVI procedure. Read more about this study
- Who is it for?
- Ages 60 years and older
- Conditions the study is for
- Aortic Stenosis, Valvular Cardiomyopathy, Aortic Valve Disease
- What is being tested?
- Cardiac imaging and 3D printing of the aortic valve
- Type of treatment
- Medical device
- How many people
- 20 participants
- Where
- 1 siteRomania
- Study dates
- 8 Jul 2022to Jul 2023
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 60 years and older
- All sexes
- Adult, Older adult
Study population: Patients with a minimum age of 60 years old, with severe degenerative aortic stenosis who present the criteria for transcatheter aortic valve intervention, who undergo coronary CCTA and CT angiography of the abdominal aorta and lower limbs, and who do not require the criteria for surgical aortic valve replacement.
Who may be able to join
- patients with degenerative aortic stenosis who present the criteria for transcatheter aortic valve intervention, who undergo coronary CCTA and CT angiography of the abdominal aorta and lower limbs.
Who cannot join
- contraindications for TAVI procedures
- patients that undergo surgical aortic valve replacement for aortic stenosis
- patients with contraindications for iodine contrast agent administration (acute renal failure, allergy, thyroid dysfunction).
- other conditions associated with suboptimal CCTA image acquisition which could interfere with CT image postprocessing for creation of 3D printed models.
Trial locations and contacts
1 site in 1 country.
Romania1 site, 1 recruiting
- Recruiting
Cardio Med Medical Center
Târgu Mureş, 540124
Theodora Benedek, PhD, MD, +40-265-217-333, theodora.benedek@gmail.com
About this study
Official title: Feasibility of 3D Printed Models of Aortic Stenosis in Guiding TAVI Procedure -the 3DP-FAST Study
- The aim of 3DP-FAST study is to analyze the accuracy of replicating cardiovascular anatomical structures using different techniques and to evaluate the feasibility of 3D printed models of aortic stenosis in guiding TAVI procedure. By conducting a comparative analysis of measurements achieved on CCTA images versus measurements obtained with a specialized projection platform by photogrammetry vs 3D printed models of various aortic valvular and perivalvular structures will be evaluated the accuracy of each step of image dataset processing. Furthermore, the study will evaluate the rate of valvular leak or peri-procedural complications such as embolic events or atrio-ventricular conduction block based on coronary computed tomography angiographic and ECG assessment at 1 year after enrollment.
Read the detailed description
The project is a prospective, cohort, mono-centric study which will be carried out in CardioMed Medical Center in collaboration with the University of Medicine, Pharmacy, Science and Technology "George Emil Palade" of Târgu Mureș.
The project will include 20 subjects who present severe aortic stenosis prior to study enrollment.
Diagnosis of severe aortic stenosis (AS) as determined by echocardiography, who are deemed eligible for TAVI by the Center of Advanced Research in Multimodal Cardiac Imaging Cardiomed Heart Valve Team.
All patients will undergo coronary CT angiography, cardiac perfusion CT and peripheral CT angiography at the moment of enrollment in the study, for complex assessment of aortic valvular and perivalvular structures as well as for peripheral vascular approach.
The study will be conducted over a period of 1 year, in which patients will be examined at baseline, and during follow-up visit. At the one-year follow-up, the study subjects will undergo CT coronary angiography for re-evaluation of the aortic valve, in the prospects of analyzing the rate of valvular leak or peri-procedural complications such as embolic events or atrio-ventricular conduction block. In case of non-presentation for the follow-up visit, patients will be contacted via telephone by one of the investigators, and questioned about the general health status, occurrence of cardiovascular or cerebrovascular symptoms and interventions, for possible non-cardiovascular related hospitalizations, as well as regarding the presence of aortic valvular disease rates/repeated interventions.
All patients will sign an informed written consent prior to being enrolled in the study. After the screening process, patients that do not present exclusion criteria will be enrolled in the study.
Study objectives:
Primary: to analyze the accuracy of replicating cardiovascular anatomical structures using different techniques and to evaluate the feasibility of 3D printed models of aortic stenosis in guiding TAVI procedure
Secondary: re-evaluation of the aortic valve, in the prospects of analyzing the rate of valvular leak or peri-procedural complications such as embolic events or atrio-ventricular conduction block.
Study Timeline:
Baseline (day 0)
- Obtain and document consent from participant on study consent form.
- Verify inclusion/exclusion criteria.
- Obtain demographic information, medical history, medication history, alcohol and tobacco use history.
- Record results of physical examinations and 12-lead ECG.
- Imaging procedures: transthoracic 2-D echocardiography, 128-multislice CT angiography (CCTA)
- 3d printed model by FDM technique based on CCTA
- Evaluation of 3D printing workflow accuracy Visit 2 (month 6)
- Follow-up after TAVI procedure
- Record results of physical examinations, 12-lead ECG and medical history.
- Imaging procedures: transthoracic 2-D echocardiography Final study visit (month 12)
- Record results of physical examinations, 12-lead ECG and medical history.
- Imaging procedures: transthoracic 2-D echocardiography, 128-multisclice CCTA
- End-point evaluation.
Study procedures:
- Clinical examination, medical history
- 12-lead ECG
- 2D transthoracic echocardiography with measurement of: cardiac diameters, volumes, valvular function and regurgitation, pressure gradients, pericardial fat thickness, pericardial effusion, left ventricular global and regional function and ejection fraction.
- 128-multislice CT coronary angiography with the evaluation of: epicardial fat volume, coronary plaque burden, total and local calcium score, aortic valve, perivalvular aortic structures, peripheral iliac vessels, ascending and descending segments of aorta.
- Processing of DICOM image dataset by performing segmentation and STL adjustments
- Processing STL image dataset by performing CAD analysis and adjustments
- Processing G-code image dataset and sending to 3d printing station
- 3D printing of aortic model including perivalvular aortic structures using fused filaments method
Data collection: In a dedicated database that includes all patient information, demographics, medical history, medication, therapeutic procedures, information derived from imaging techniques (echocardiography, CT angiography, CT imaging post-processing and shear stress evaluation).
- Being tested
- Cardiac imaging, 3D printing of the aortic valve
- Keywords
- aortic stenosis, 3D printing, interventional planning, cardiovascular models, TAVI, Accuracy
- Medical subject headings
- Aortic Valve Stenosis, Aortic Valve Disease
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Cardiac imagingDiagnostic test
Baseline - 2D transthoracic echocardiography, 128-multislice CT coronary angiography, CCTA of peripheral lower limbs vessels 12-months follow-up - 128-multislice CT coronary angiography with transthoracic echocardiography
3D printing of the aortic valveDevice
3D printing of the aortic valve based on CCTA image acquisition
What is being measured
The primary outcome is the main question the study is designed to answer.
Feasibility of 3D printed models of aortic valves in guiding TAVI procedure
Analysis of the accuracy of replicating cardiovascular anatomical structures using different techniques and to evaluate the feasibility of 3D printed models of aortic stenosis in guiding TAVI procedure.
Measured: at baseline
Rate of complications during 12 months follow-up of patients undergoing TAVI for aortic stenosis
Re-evaluation of the aortic valve, in the prospects of analyzing the rate of valvular leak or peri-procedural complications such as embolic events or atrio-ventricular conduction block during a 12 months follow-up after TAVI procedure.
Measured: 12 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted2 Aug 2022
- Study start8 Jul 2022
- Primary completionJul 2023 (estimated)
- Study completionJul 2023 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (4)Papers the sponsor has linked to this study.
- Other trials for Aortic StenosisStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 20 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Cardio Med Medical Center
- Sponsor type
- Industry (pharma, biotech, devices)
- Collaborators
- George Emil Palade University of Medicine, Pharmacy, Sciences and Technology of Targu Mures, University Hospital of Targu Mures, Romania
- Responsible party
- Sponsor
- Investigators
- Daniel Cernica, MD, Study director, CardioMed Medical Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05484713
- Sponsor's protocol ID
- CM-G510-3DP
- Acronym
- 3DP-FAST
- Status last verified
- Jul 2022
- First submitted
- 30 Jul 2022
- Last updated
- 16 May 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: All IPD that underlie results in a publication will be available for interested parties.
Publications
Cernica D, Benedek I, Polexa S, Tolescu C, Benedek T. 3D Printing-A Cutting Edge Technology for Treating Post-Infarction Patients. Life (Basel). 2021 Sep 1;11(9):910. doi: 10.3390/life11090910.
PubMed 34575059Benedek A, Cernica D, Mester A, Opincariu D, Hodas R, Rodean I, Keri J, Benedek T. Modern Concepts in Regenerative Therapy for Ischemic Stroke: From Stem Cells for Promoting Angiogenesis to 3D-Bioprinted Scaffolds Customized via Carotid Shear Stress Analysis. Int J Mol Sci. 2019 May 25;20(10):2574. doi: 10.3390/ijms20102574.
PubMed 31130624Wang DD, Qian Z, Vukicevic M, Engelhardt S, Kheradvar A, Zhang C, Little SH, Verjans J, Comaniciu D, O'Neill WW, Vannan MA. 3D Printing, Computational Modeling, and Artificial Intelligence for Structural Heart Disease. JACC Cardiovasc Imaging. 2021 Jan;14(1):41-60. doi: 10.1016/j.jcmg.2019.12.022. Epub 2020 Aug 26.
PubMed 32861647Vukicevic M, Mosadegh B, Min JK, Little SH. Cardiac 3D Printing and its Future Directions. JACC Cardiovasc Imaging. 2017 Feb;10(2):171-184. doi: 10.1016/j.jcmg.2016.12.001.
PubMed 28183437
Study at a glance
From the registry record, last updated by the sponsor on 16 May 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Feasibility of 3D Printed Models of Aortic Stenosis in Guiding TAVI Procedure -the 3DP-FAST Study
- ClinicalTrials.gov ID
- NCT05484713
- Acronym / sponsor ID
- 3DP-FAST / CM-G510-3DP
- Keywords
- aortic stenosis, 3D printing, interventional planning, cardiovascular models, TAVI, Accuracy
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 20 participants (estimated)
- Lead sponsor
- Cardio Med Medical CenterIndustry (pharma, biotech, devices)
- Collaborators
- George Emil Palade University of Medicine, Pharmacy, Sciences and Technology of Targu Mures, University Hospital of Targu Mures, Romania
- Study start
- 8 Jul 2022 (actual)
- Primary completion
- Jul 2023 (estimated)
- Study completion
- Jul 2023 (estimated)
- First posted
- 2 Aug 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
- The aim of 3DP-FAST study is to analyze the accuracy of replicating cardiovascular anatomical structures using different techniques and to evaluate the feasibility of 3D printed models of aortic stenosis in guiding TAVI procedure. By conducting a comparative analysis of measurements achieved on CCTA images versus measurements obtained with a specialized projection platform by photogrammetry vs 3D printed models of various aortic valvular and perivalvular structures will be evaluated the accuracy of each step of image dataset processing. Furthermore, the study will evaluate the rate of valvular leak or peri-procedural complications such as embolic events or atrio-ventricular conduction block based on coronary computed tomography angiographic and ECG assessment at 1 year after enrollment.
Detailed description
The project is a prospective, cohort, mono-centric study which will be carried out in CardioMed Medical Center in collaboration with the University of Medicine, Pharmacy, Science and Technology "George Emil Palade" of Târgu Mureș.
The project will include 20 subjects who present severe aortic stenosis prior to study enrollment.
Diagnosis of severe aortic stenosis (AS) as determined by echocardiography, who are deemed eligible for TAVI by the Center of Advanced Research in Multimodal Cardiac Imaging Cardiomed Heart Valve Team.
All patients will undergo coronary CT angiography, cardiac perfusion CT and peripheral CT angiography at the moment of enrollment in the study, for complex assessment of aortic valvular and perivalvular structures as well as for peripheral vascular approach.
The study will be conducted over a period of 1 year, in which patients will be examined at baseline, and during follow-up visit. At the one-year follow-up, the study subjects will undergo CT coronary angiography for re-evaluation of the aortic valve, in the prospects of analyzing the rate of valvular leak or peri-procedural complications such as embolic events or atrio-ventricular conduction block. In case of non-presentation for the follow-up visit, patients will be contacted via telephone by one of the investigators, and questioned about the general health status, occurrence of cardiovascular or cerebrovascular symptoms and interventions, for possible non-cardiovascular related hospitalizations, as well as regarding the presence of aortic valvular disease rates/repeated interventions.
All patients will sign an informed written consent prior to being enrolled in the study. After the screening process, patients that do not present exclusion criteria will be enrolled in the study.
Study objectives:
Primary: to analyze the accuracy of replicating cardiovascular anatomical structures using different techniques and to evaluate the feasibility of 3D printed models of aortic stenosis in guiding TAVI procedure
Secondary: re-evaluation of the aortic valve, in the prospects of analyzing the rate of valvular leak or peri-procedural complications such as embolic events or atrio-ventricular conduction block.
Study Timeline:
Baseline (day 0)
- Obtain and document consent from participant on study consent form.
- Verify inclusion/exclusion criteria.
- Obtain demographic information, medical history, medication history, alcohol and tobacco use history.
- Record results of physical examinations and 12-lead ECG.
- Imaging procedures: transthoracic 2-D echocardiography, 128-multislice CT angiography (CCTA)
- 3d printed model by FDM technique based on CCTA
- Evaluation of 3D printing workflow accuracy Visit 2 (month 6)
- Follow-up after TAVI procedure
- Record results of physical examinations, 12-lead ECG and medical history.
- Imaging procedures: transthoracic 2-D echocardiography Final study visit (month 12)
- Record results of physical examinations, 12-lead ECG and medical history.
- Imaging procedures: transthoracic 2-D echocardiography, 128-multisclice CCTA
- End-point evaluation.
Study procedures:
- Clinical examination, medical history
- 12-lead ECG
- 2D transthoracic echocardiography with measurement of: cardiac diameters, volumes, valvular function and regurgitation, pressure gradients, pericardial fat thickness, pericardial effusion, left ventricular global and regional function and ejection fraction.
- 128-multislice CT coronary angiography with the evaluation of: epicardial fat volume, coronary plaque burden, total and local calcium score, aortic valve, perivalvular aortic structures, peripheral iliac vessels, ascending and descending segments of aorta.
- Processing of DICOM image dataset by performing segmentation and STL adjustments
- Processing STL image dataset by performing CAD analysis and adjustments
- Processing G-code image dataset and sending to 3d printing station
- 3D printing of aortic model including perivalvular aortic structures using fused filaments method
Data collection: In a dedicated database that includes all patient information, demographics, medical history, medication, therapeutic procedures, information derived from imaging techniques (echocardiography, CT angiography, CT imaging post-processing and shear stress evaluation).
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 60 years and older
- Sex
- All
- Age groups
- Adult, Older adult
- Study population
- Patients with a minimum age of 60 years old, with severe degenerative aortic stenosis who present the criteria for transcatheter aortic valve intervention, who undergo coronary CCTA and CT angiography of the abdominal aorta and lower limbs, and who do not require the criteria for surgical aortic valve replacement.
Key inclusion criteria (1 listed)
- patients with degenerative aortic stenosis who present the criteria for transcatheter aortic valve intervention, who undergo coronary CCTA and CT angiography of the abdominal aorta and lower limbs.
Key exclusion criteria (4 listed)
- contraindications for TAVI procedures
- patients that undergo surgical aortic valve replacement for aortic stenosis
- patients with contraindications for iodine contrast agent administration (acute renal failure, allergy, thyroid dysfunction).
- other conditions associated with suboptimal CCTA image acquisition which could interfere with CT image postprocessing for creation of 3D printed models.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Cardiac imagingBaseline - 2D transthoracic echocardiography, 128-multislice CT coronary angiography, CCTA of peripheral lower limbs vessels 12-months follow-up - 128-multislice CT coronary angiography with transthoracic echocardiography | Diagnostic test | – |
| 3D printing of the aortic valve3D printing of the aortic valve based on CCTA image acquisition | Device | – |
Primary outcome
Feasibility of 3D printed models of aortic valves in guiding TAVI procedure
Time frame: at baseline
Analysis of the accuracy of replicating cardiovascular anatomical structures using different techniques and to evaluate the feasibility of 3D printed models of aortic stenosis in guiding TAVI procedure.
Rate of complications during 12 months follow-up of patients undergoing TAVI for aortic stenosis
Time frame: 12 months
Re-evaluation of the aortic valve, in the prospects of analyzing the rate of valvular leak or peri-procedural complications such as embolic events or atrio-ventricular conduction block during a 12 months follow-up after TAVI procedure.
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 16 May 2023.
- Background: PubMed 34575059Cernica D, Benedek I, Polexa S, Tolescu C, Benedek T. 3D Printing-A Cutting Edge Technology for Treating Post-Infarction Patients. Life (Basel). 2021 Sep 1;11(9):910. doi: 10.3390/life11090910.
- Background: PubMed 31130624Benedek A, Cernica D, Mester A, Opincariu D, Hodas R, Rodean I, Keri J, Benedek T. Modern Concepts in Regenerative Therapy for Ischemic Stroke: From Stem Cells for Promoting Angiogenesis to 3D-Bioprinted Scaffolds Customized via Carotid Shear Stress Analysis. Int J Mol Sci. 2019 May 25;20(10):2574. doi: 10.3390/ijms20102574.
- Background: PubMed 32861647Wang DD, Qian Z, Vukicevic M, Engelhardt S, Kheradvar A, Zhang C, Little SH, Verjans J, Comaniciu D, O'Neill WW, Vannan MA. 3D Printing, Computational Modeling, and Artificial Intelligence for Structural Heart Disease. JACC Cardiovasc Imaging. 2021 Jan;14(1):41-60. doi: 10.1016/j.jcmg.2019.12.022. Epub 2020 Aug 26.
- Background: PubMed 28183437Vukicevic M, Mosadegh B, Min JK, Little SH. Cardiac 3D Printing and its Future Directions. JACC Cardiovasc Imaging. 2017 Feb;10(2):171-184. doi: 10.1016/j.jcmg.2016.12.001.
- Individual participant dataSharing planned: Yes. All IPD that underlie results in a publication will be available for interested parties.
Related trials for Aortic Stenosis
Recruiting
Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR
Aortic Stenosis Treated With TAVI, Aortic Diseases
Not yet recruiting
Human Experimental Models of Pain (HEMP)
Acute Pain
Active, not recruitingObservational study
Intravascular Lithotripsy in High Risk Calcified Iliac Anatomy for Transfemoral TAVR
Iliac Disease, Aortic Valve Stenosis
Not yet recruiting
NHLBI SESAME (SEptal Scoring Along Midline Endocardium) Multi-Center Prospective Study Using Improvised Off-Label Devices
Hypertrophic Cardiomyopathy, Left Ventricular Outflow Obstruction
Recruiting
Exercise and Diet Supplements for Older Patients Undergoing TAVI: the IRON-TAVI Trial
Aortic Stenosis Disease, Aortic Stenosis Symptomatic
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Daniel Cernica, MD study director
CardioMed Medical Center
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Aortic Stenosis and Valvular Cardiomyopathy, run by Cardio Med Medical Center at 1 site in Romania.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 16 May 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Romania. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Daniel Cernica, MD (+40 265 217 333, daniel.cernica@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Feasibility of 3D printed models of aortic valves in guiding TAVI procedure (time frame: at baseline). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT05484713, which also lists 4 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 May 2023.